US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist

21.910
+0.880+4.18%

Close Nov 26 16:00 ET

21.910
0.0000.00%

Post 17:28 ET

1.74BMarket Cap-5071P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-73.68%-67.71M

-1.87%-46.06M

27.03%-45.22M

-96.26%-184.17M

-11.63%-38M

-88.62%-38.98M

-149.99%-45.21M

-194.52%-61.97M

-71.92%-93.84M

-105.88%-34.04M

Net income from continuing operations

-60.91%-76.69M

-18.03%-64.99M

28.77%-48.54M

-83.05%-237.73M

-46.03%-66.86M

-64.88%-47.66M

-86.71%-55.06M

-165.25%-68.15M

-63.54%-129.87M

-58.17%-45.79M

Operating gains losses

----

--182K

--1K

----

Depreciation and amortization

-3.70%130K

7.58%142K

38.10%145K

104.71%522K

56.25%150K

117.74%135K

131.58%132K

162.50%105K

112.50%255K

200.00%96K

Other non cash items

-93.25%93K

-93.90%306K

12.63%107K

2,401.14%6.6M

128.57%112K

1,047.50%1.38M

10,356.25%5.02M

102.13%95K

-96.47%264K

-99.36%49K

Change In working capital

172.69%2.97M

337.02%11.13M

20.84%-4.96M

-159.05%-9.43M

-22.61%5.62M

-239.88%-4.08M

-176.28%-4.7M

-1,597.29%-6.26M

825.87%15.96M

657.52%7.26M

-Change in receivables

---14K

292.31%102K

--0

115.12%26K

63.38%-26K

177.38%349K

960.71%297K

-Change in prepaid assets

-454.43%-4M

188.79%3.13M

-113.66%-4.47M

36.90%-2.11M

432.22%2.38M

202.36%1.13M

-351.67%-3.52M

-182.97%-2.09M

-123.20%-3.34M

-191.81%-717K

-Change in payables and accrued expense

237.23%7.05M

807.82%7.97M

89.88%-412K

-136.54%-7.03M

-57.34%3.31M

-235.31%-5.14M

-115.68%-1.13M

-892.02%-4.07M

533.94%19.24M

3,422.27%7.75M

-Change in other working capital

0.00%-72K

0.00%-288K

0.00%-72K

-145.28%-288K

-1.41%-72K

Cash from discontinued investing activities

Operating cash flow

-73.68%-67.71M

-1.87%-46.06M

27.03%-45.22M

-96.26%-184.17M

-11.63%-38M

-88.62%-38.98M

-149.99%-45.21M

-194.52%-61.97M

-71.92%-93.84M

-105.88%-34.04M

Investing cash flow

Cash flow from continuing investing activities

-276.24%-84.67M

52.23%61.98M

-975.93%-143.05M

18.13%-94.25M

6.03%-169.71M

12.64%48.04M

191.58%40.71M

-250.01%-13.3M

-54.96%-115.13M

-125.16%-180.6M

Net PPE purchase and sale

27.48%-293K

68.58%-104K

--0

-12.67%-898K

79.22%-48K

-325.26%-404K

-13.36%-331K

35.75%-115K

-207.72%-797K

-181.71%-231K

Net investment purchase and sale

-274.16%-84.37M

51.25%62.08M

-985.32%-143.05M

18.35%-93.35M

5.94%-169.66M

13.33%48.45M

187.93%41.04M

-245.76%-13.18M

-54.43%-114.33M

-125.10%-180.37M

Cash from discontinued investing activities

Investing cash flow

-276.24%-84.67M

52.23%61.98M

-975.93%-143.05M

18.13%-94.25M

6.03%-169.71M

12.64%48.04M

191.58%40.71M

-250.01%-13.3M

-54.96%-115.13M

-125.16%-180.6M

Financing cash flow

Cash flow from continuing financing activities

1,485.19%245.02M

-96.48%108K

2,058.48%177.08M

-29.97%225.67M

664.75%198.94M

-94.69%15.46M

-32.69%3.07M

1,011.65%8.2M

157.23%322.24M

15,202.35%26.01M

Net issuance payments of debt

----

200.00%15M

--0

----

--5M

--446K

Net common stock issuance

--233.75M

--0

--186.27M

-57.15%125.07M

398.56%125.07M

--0

155.49%291.87M

2,398.61%25.09M

Net preferred stock issuance

----

73.16%76.19M

--76.19M

----

159.43%44M

--0

Proceeds from stock option exercised by employees

46.86%1.43M

-93.16%210K

-85.45%1.19M

459.90%21.72M

411.38%9.48M

-24.38%971K

76,600.00%3.07M

1,011.65%8.2M

65.04%3.88M

73.43%1.85M

Net other financing activities

---15.15M

---102K

---10.38M

45.29%-12.32M

-760.13%-11.8M

----

-171.93%-22.51M

27.90%-1.37M

Cash from discontinued financing activities

Financing cash flow

1,485.19%245.02M

-96.48%108K

2,058.48%177.08M

-29.97%225.67M

664.75%198.94M

-94.69%15.46M

-32.69%3.07M

1,011.65%8.2M

157.23%322.24M

15,202.35%26.01M

Net cash flow

Beginning cash position

23.64%107.67M

3.53%91.64M

-33.91%102.83M

267.81%155.58M

-67.58%111.6M

178.28%87.08M

186.85%88.52M

267.81%155.58M

-7.84%42.3M

147.86%344.21M

Current changes in cash

277.93%92.65M

1,218.35%16.03M

83.32%-11.19M

-146.57%-52.75M

95.35%-8.77M

-92.17%24.52M

-429.43%-1.43M

-486.17%-67.06M

3,248.42%113.28M

-95.32%-188.63M

End cash Position

79.50%200.32M

23.64%107.67M

3.53%91.64M

-33.91%102.83M

-67.58%111.6M

178.28%87.08M

186.85%88.52M

267.81%155.58M

Free cash flow

-72.64%-68M

-1.35%-46.16M

27.16%-45.22M

-95.56%-185.07M

-11.01%-38.05M

-89.70%-39.39M

-147.82%-45.55M

-192.58%-62.09M

-72.32%-94.64M

-106.23%-34.27M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-73.68%-67.71M	-1.87%-46.06M	27.03%-45.22M	-96.26%-184.17M	-11.63%-38M	-88.62%-38.98M	-149.99%-45.21M	-194.52%-61.97M	-71.92%-93.84M	-105.88%-34.04M
Net income from continuing operations	-60.91%-76.69M	-18.03%-64.99M	28.77%-48.54M	-83.05%-237.73M	-46.03%-66.86M	-64.88%-47.66M	-86.71%-55.06M	-165.25%-68.15M	-63.54%-129.87M	-58.17%-45.79M
Operating gains losses	----	----	----	--182K	--1K	----	----	----	----	----
Depreciation and amortization	-3.70%130K	7.58%142K	38.10%145K	104.71%522K	56.25%150K	117.74%135K	131.58%132K	162.50%105K	112.50%255K	200.00%96K
Other non cash items	-93.25%93K	-93.90%306K	12.63%107K	2,401.14%6.6M	128.57%112K	1,047.50%1.38M	10,356.25%5.02M	102.13%95K	-96.47%264K	-99.36%49K
Change In working capital	172.69%2.97M	337.02%11.13M	20.84%-4.96M	-159.05%-9.43M	-22.61%5.62M	-239.88%-4.08M	-176.28%-4.7M	-1,597.29%-6.26M	825.87%15.96M	657.52%7.26M
-Change in receivables	---14K	292.31%102K	--0	--0	--0	--0	115.12%26K	63.38%-26K	177.38%349K	960.71%297K
-Change in prepaid assets	-454.43%-4M	188.79%3.13M	-113.66%-4.47M	36.90%-2.11M	432.22%2.38M	202.36%1.13M	-351.67%-3.52M	-182.97%-2.09M	-123.20%-3.34M	-191.81%-717K
-Change in payables and accrued expense	237.23%7.05M	807.82%7.97M	89.88%-412K	-136.54%-7.03M	-57.34%3.31M	-235.31%-5.14M	-115.68%-1.13M	-892.02%-4.07M	533.94%19.24M	3,422.27%7.75M
-Change in other working capital	0.00%-72K	0.00%-72K	0.00%-72K	0.00%-288K	0.00%-72K	0.00%-72K	0.00%-72K	0.00%-72K	-145.28%-288K	-1.41%-72K
Cash from discontinued investing activities
Operating cash flow	-73.68%-67.71M	-1.87%-46.06M	27.03%-45.22M	-96.26%-184.17M	-11.63%-38M	-88.62%-38.98M	-149.99%-45.21M	-194.52%-61.97M	-71.92%-93.84M	-105.88%-34.04M
Investing cash flow
Cash flow from continuing investing activities	-276.24%-84.67M	52.23%61.98M	-975.93%-143.05M	18.13%-94.25M	6.03%-169.71M	12.64%48.04M	191.58%40.71M	-250.01%-13.3M	-54.96%-115.13M	-125.16%-180.6M
Net PPE purchase and sale	27.48%-293K	68.58%-104K	--0	-12.67%-898K	79.22%-48K	-325.26%-404K	-13.36%-331K	35.75%-115K	-207.72%-797K	-181.71%-231K
Net investment purchase and sale	-274.16%-84.37M	51.25%62.08M	-985.32%-143.05M	18.35%-93.35M	5.94%-169.66M	13.33%48.45M	187.93%41.04M	-245.76%-13.18M	-54.43%-114.33M	-125.10%-180.37M
Cash from discontinued investing activities
Investing cash flow	-276.24%-84.67M	52.23%61.98M	-975.93%-143.05M	18.13%-94.25M	6.03%-169.71M	12.64%48.04M	191.58%40.71M	-250.01%-13.3M	-54.96%-115.13M	-125.16%-180.6M
Financing cash flow
Cash flow from continuing financing activities	1,485.19%245.02M	-96.48%108K	2,058.48%177.08M	-29.97%225.67M	664.75%198.94M	-94.69%15.46M	-32.69%3.07M	1,011.65%8.2M	157.23%322.24M	15,202.35%26.01M
Net issuance payments of debt	----	----	----	200.00%15M	--0	----	----	----	--5M	--446K
Net common stock issuance	--233.75M	--0	--186.27M	-57.15%125.07M	398.56%125.07M	--0	--0	--0	155.49%291.87M	2,398.61%25.09M
Net preferred stock issuance	----	----	----	73.16%76.19M	--76.19M	----	----	----	159.43%44M	--0
Proceeds from stock option exercised by employees	46.86%1.43M	-93.16%210K	-85.45%1.19M	459.90%21.72M	411.38%9.48M	-24.38%971K	76,600.00%3.07M	1,011.65%8.2M	65.04%3.88M	73.43%1.85M
Net other financing activities	---15.15M	---102K	---10.38M	45.29%-12.32M	-760.13%-11.8M	----	----	----	-171.93%-22.51M	27.90%-1.37M
Cash from discontinued financing activities
Financing cash flow	1,485.19%245.02M	-96.48%108K	2,058.48%177.08M	-29.97%225.67M	664.75%198.94M	-94.69%15.46M	-32.69%3.07M	1,011.65%8.2M	157.23%322.24M	15,202.35%26.01M
Net cash flow
Beginning cash position	23.64%107.67M	3.53%91.64M	-33.91%102.83M	267.81%155.58M	-67.58%111.6M	178.28%87.08M	186.85%88.52M	267.81%155.58M	-7.84%42.3M	147.86%344.21M
Current changes in cash	277.93%92.65M	1,218.35%16.03M	83.32%-11.19M	-146.57%-52.75M	95.35%-8.77M	-92.17%24.52M	-429.43%-1.43M	-486.17%-67.06M	3,248.42%113.28M	-95.32%-188.63M
End cash Position	79.50%200.32M	23.64%107.67M	3.53%91.64M	-33.91%102.83M	-33.91%102.83M	-67.58%111.6M	178.28%87.08M	186.85%88.52M	267.81%155.58M	267.81%155.58M
Free cash flow	-72.64%-68M	-1.35%-46.16M	27.16%-45.22M	-95.56%-185.07M	-11.01%-38.05M	-89.70%-39.39M	-147.82%-45.55M	-192.58%-62.09M	-72.32%-94.64M	-106.23%-34.27M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data